Growth and development: Congenital adrenal hyperplasiaglucocorticoids and height

Nature Reviews Endocrinology

Volumn 6, Issue 1, 2010, Pages 14-15

  Speiser, Phyllis W ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; HYDROXYPROGESTERONE; PREDNISOLONE; TESTOSTERONE;

ANDROSTENEDIONE BLOOD LEVEL; BODY HEIGHT; BONE AGE; CONGENITAL ADRENAL HYPERPLASIA; DRUG DOSE TITRATION; DRUG MEGADOSE; EPIPHYSIS; GROWTH INHIBITION; HUMAN; HYPOTENSION; MENARCHE; PHARMACOGENOMICS; PRIORITY JOURNAL; PUBERTY; RECOMMENDED DRUG DOSE; SHORT STATURE; SHORT SURVEY; SODIUM BALANCE; STEROID THERAPY; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL; VIRILIZATION;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; BODY HEIGHT; FEMALE; GLUCOCORTICOIDS; GROWTH DISORDERS; HUMANS; MALE;

EID: 73949112451     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.242     Document Type: Short Survey

References (10)

1. Bonfig, W. et al. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence based recommendation. J. Clin. Endocrinol. 94, 3882-3888 (2009).
2. Hargitai, G. et al. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency: results of a multicenter study. Horm. Res. 55, 161-171 (2001).
3. Punthakee, Z., Legault, L. & Polychronakos, C. Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. J. Pediatr. 143, 402-405 (2003).
4. Rivkees, S. A. & Crawford, J. D. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 106, 767-773 (2000).
5. Aycan, Z. et al. experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential. J. Pediatr. Endocrinol. Metab. 19, 245-251 (2006).
6. Jääskeläinen, J. & voutilainen, R. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatr. Res. 41, 30-33 (1997).
7. silva, I. N., Kater, C. E., Cunha, C. F. & viana, M. B. Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia. Arch. Dis. Child. 77, 214-218 (1997).
8. Clayton, P. E. et al. Consensus statement on 21-hydroxylase deficiency from the Lawson wilkins Pediatric endocrine society and The european society for Pediatric endocrinology. J. Clin. Endocrinol. Metab. 87, 4048-4053 (2002).
9. Merke, D. P. et al. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 85, 1114-1120 (2000).
10. Lin-su, K. et al. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 90, 3318-3325 (2005).